EBioMedicine · 2024 · 13 citations · 57 references
MedicineNeurobiologyNeuroscienceNeurodegenerationNeuromuscular DisordersNeuropathologyHepatic PathophysiologyLiver DiseaseMuscular DystrophyNeurodegenerative DiseasesNeurodegenerative DisordersSpinal Muscular AtrophyMotor Neuron Disease ModelsMotor Neuron FunctionMuscular Dystrophy PathophysiologySurvival Motor Neuron Protein Deficiency
BACKGROUND: The liver is a key metabolic organ, acting as a hub to metabolically connect various tissues. Spinal muscular atrophy (SMA) is a neuromuscular disorder whereby patients have an increased susceptibility to developing dyslipidaemia and liver steatosis. It remains unknown whether fatty liver is due to an intrinsic or extrinsic impact of survival motor neuron (SMN) protein depletion. METHODS: mice, a model of SMA. Experiments assessed central and peripheral impacts using immunoblot, immunohistochemistry, and electron microscopy techniques. FINDINGS: mice. Fatty liver was ameliorated while key markers of liver function were also restored to normal levels. Certain peripheral pathologies were rescued including muscle size and pancreatic cell imbalance. Only a partial CNS recovery was seen using a liver therapeutic strategy alone. INTERPRETATION: mice. FUNDING: This work was funded by Muscular Dystrophy Association (USA) [grant number 963652 to R.K.]; the Canadian Institutes of Health Research [grant number PJT-186300 to R.K.].
57
Correlation between severity and SMN protein level in spinal muscular atrophy
Suzie Lefebvre, Philippe Burlet, Qing Liu et al. · Nature Genetics · 1997 · 1.1K citations
Medicine, Neurology, Neuroscience +11
Preethi Srikanthan, Arun S. Karlamangla · The Journal of Clinical Endocrinology & Metabolism · 2011 · 775 citations
Medicine, Endocrinology, Nutrition +16